Skip to main content

Table 5 Anti-inflammatory and pro-inflammatory cytokine profiles and results for healthy and T2DM volunteers

From: Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation

Multiplex cytokine results

Cytokines (pg mL−1)

Healthy (n = 23)

T2DM (n = 25)

Adjusted OR (95% CI)

Mann–Whitney P-value

Anti-inflammatory markers

 IFN-α

1.35 [0.74–1.63]

2.28 [1.94–2.49]

1.03 (0.75, 1.45)

0.003

 IL-10

2.74 [1.89–5.29]

9.6 [4.62–16.27]

1.17 (1.05, 1.36)

0.0002

 IL-13

2.25 [0.665–7.03]

5.75 [2.56–10.01]

1.03 (0.93, 1.15)

0.045

 IL-4

7.09 [2.3–20.6]

29.63 [15.3–78.5]

1.01 (1, 1.03)

0.004

Pro-inflammatory markers

 E-Selectin

25,885 [19,418–30,622]

24,782 [18,633–35,779]

1 (1, 1)

0.902

 GM-CSF

0.001 [0.001–18]

29.18 [15.61–60]

1.02 (1, 1.04)

0.001

 IFN-γ

4.12 [0.001–12.6]

12.03 [7.1–19.3]

1.02 (0.98, 1.08)

0.007

 IL-1α

3.49 [2.45–5.2]

11.33 [3.6–24.9]

1.12 (1.04, 1.23)

0.003

 IL-1β

16.47 [11.4–30.3]

48.98 [33.8–76.6]

1.02 (1, 1.05)

0.00005

 IL-12p70

12.03 [6.7–15.4]

22.92 [16.4–30.8]

1.16 (1.06, 1.3)

0.00015

 IL-17A

0.001 [0.001–0.97]

4.11 [1.05–8.47]

1.09 (0.99, 1.24)

0.0005

 IL-6

8.43 [0.44–21.18]

239.41 [31–1018]

1 (1, 1.01)

0.00005

 IL-8

1.33 [0.001–15.6]

36.32 [3.83–69.5]

1.02 (1, 1.04)

0.003

 IP-10

18.12 [15.2–27.1]

30.8 [23.0–149.6]

1.01 (1, 1.03)

0.005

 MCP-1

39.98 [24.8–54.4]

65.3 [43.4–134.2]

1.04 (1.02, 1.08)

0.0002

 MIP-1α

20.94 [4.31–70.7]

63.82 [14.7–108]

1.01 (1, 1.02)

0.083

 MIP-1β

39.9 [20.7–424.6]

317.1 [65.2–565.4]

1 (1, 1)

0.016

 P-Selectin

9080 [6318–12,792]

11,967 [9626–16,135]

1 (1, 1)

0.03

 sICAM-1

39,140 [27,732–59,821]

47,253 [29,219–58,020]

1 (1, 1)

0.79

 TNF-α

86.3 [68.9–121.5]

161.7 [98.6–197.5]

1.01 (1, 1.03)

0.012

  1. Summary statistics are given as median and [IQR]. Significant differences are shown in italics for both models